Kira AjasStark / Raving Health, a leading clinical trial marketing agency specializing in patient recruitment, is pleased to announce the appointment of Kira Ajas as the company’s new Junior Production Designer.

In her new role, Kira will play an important role in supporting Stark / Raving Health’s production capabilities and contributing to the creative vision of the organization. With a love for visual systems, typography, and animation, Kira brings a wealth of creativity and technical know-how to the Stark / Raving Health production group.

“We are thrilled to welcome Kira Ajas to the Production Department,” said Bob Hunter, Production Manager at Stark / Raving Health. “Her unique perspective and enthusiasm will undoubtedly contribute to our ongoing mission of delivering high quality print and digital tools that support clinical research. We are confident that Kira’s talents will further enhance our capabilities as we continue to expand our team and our offerings.”

Kira’s background in graphic design and keen eye for detail make her a valuable addition to the company. She holds a degree in Graphic Design from Boston University, where she honed her skills in translating concepts into visually compelling designs.

“With recent additions to our team, we have significantly enhanced our capabilities and strengthen our commitment to being a leading clinical trial marketing agency,” said Matthew Stumm, President and Founder. “Our most recent hires bring diverse expertise, innovative perspectives, and a wealth of experience to our organization, enhancing our ability to deliver on the evolving needs of our valued Sponsors and CRO partners.”

About Stark / Raving Health
Stark / Raving Health is an independently owned patient recruitment agency that accelerates global clinical trial enrollment using engaging study toolkits, patient-centric digital experiences, and targeted media outreach campaigns. Our approach is built on 20+ years of successfully delivering hundreds of patient recruitment campaigns across a range of therapeutic areas in more than 40 countries and over 70 languages. Our ability to scale our streamlined approach and successfully deliver patients has made us a go-to resource for the world’s leading biotechs, pharmaceutical companies, and CROs.

To learn more, visit